Cross-cancer comparative analyses further indicate that HCC TANs show unique metabolic programming, characterised by upregulation of glycolytic genes (HK2, PFKP) and fatty acid oxidation genes (carnitine palmitoyltransferase 1A[CPT1A]). The gene discussed is CPT1A; the disease is cancer.